Artelo Biosciences, Inc. (ARTL) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Artelo Biosciences, Inc. (ARTL) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.3M, listed on NASDAQ, employing roughly 6 people, carrying a beta of -0.14 to the broader market. Artelo Biosciences, Inc. Led by Gregory D. Gorgas, public since 2019-06-21.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for ARTL as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →